x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Molecule to Market: Inside the outsourcing space

Molecule to Market takes you inside the global pharma and biopharma outsourcing ecosystem. Each week, our host Raman Sehgal sits down with the founders, entrepreneurs, CEOs and C-suite leaders shaping the pharma services and tools that power discovery, drug development and commercialization. Listeners get real stories and practical insights from across the entire value chain, from big pharma and emerging biotechs to private equity investors, CROs, CDMOs, technology platforms and specialist

science life sciences

All Episodes

46:22

The life science dating agent

Molecule to Market: Inside the outsourcing space ·

2021/10/04

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Martino Picardo, Chairman at Discovery Park. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Martino, covering: His ‘three careers’ over the last few decades, mainly spent translating science into commercial entities that make a difference. Building Stevenage Bioscience Catalyst from the ground-up from the middle of the golden triangle

en

03:37

A little, big announcement...

Molecule to Market: Inside the outsourcing space ·

2021/09/16

After years of frustration with recruitment service providers in our space and seeing many of my CRO/CDMO connections miss their growth targets because their talent agenda just can’t keep up, I decided to create a talent sourcing solution for pharma & bio outsourcing. Proudly introducing, Lead Candidate. The business has been founded purely to support ambitious, growing CROs, CDMOs and pharma service firms. Lead Candidate aims to help address many of the common issues we see guests talk about -

en

48:09

The CDMO start-up... with a heck of a track record

Molecule to Market: Inside the outsourcing space ·

2021/09/03

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug product and sterile injectables sector with Cory Lewis CEO and President, Founder at INCOG BioPharma Services. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Cory, covering: The incredible 10-year journey of Cook Pharmica from a burning cash turnaround challenge to a $950M acquisition by Catalent. Customer-centric lessons learned from the franchise business

en

44:05

From Big Pharma to CDMO leader

Molecule to Market: Inside the outsourcing space ·

2021/08/12

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Dr. Louise Duffy, Ph.D., SVP and Head of the Scientific Project Leaders at Abzena. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Louise, covering: Learnings for CDMOs after almost three decades spent with big pharma. How to balance the juggling act between dealing with hundreds of projects, clients, and systems as a fast-growing large

en

41:09

The change optimist

Molecule to Market: Inside the outsourcing space ·

2021/07/15

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Sébastien Ribault, Vice President & Head of End to End CDMO Services, Process Solutions at Merck Life Science. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Sébastien, covering: The ever-changing world of biotech and how things talked about 20 years ago are now becoming a reality for many treatments. Re-inventing the drug development

en

43:07

The Public Health vaccine specialist

Molecule to Market: Inside the outsourcing space ·

2021/07/08

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Vanessa Elharrar PPD, VP, Vaccines Business Strategy Lead, at PPD Vaccine Clinical Development and Medical Affairs. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Vanessa, covering: Being at the centre of vaccine development and patient distribution over the last year. And the global pandemic’s role as a day of reckoning for the

en

29:47

The academic turned biopharma innovator

Molecule to Market: Inside the outsourcing space ·

2021/06/30

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with JaeB Kim, Managing Director at Samsung Biologics America. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with JaeB, covering: A year at one of the largest and fastest-growing CDMOs in the world. Growing a US presence within the thriving biopharma cluster in San Francisco Bay with ambitious plans for future expansion. The need for industry to

en

42:04

From chemist to consultant

Molecule to Market: Inside the outsourcing space ·

2021/06/25

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Urvish Pandya, Managing Director at Allotrope Scientific Ltd. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Urvish, covering: The exponential growth of chemistry in India leading to the production of many fine Indian chemists all over the world. Honest advice on how to deal with being made redundant as a result of being caught in the

en

32:10

2021 mid-year CDMO Review: COVID-19 Vaccine...

Molecule to Market: Inside the outsourcing space ·

2021/06/23

In today’s special ‘bite-sized’ Molecule to Market episode, I’ll be talking with Jim Miller about the CDMO space at the half point mark in 2012. Inspired by this terrific article https://www.dcatvci.org/7173-mid-year-cdmo-review-covid-19-vaccine-manufacturing-and-m-a on the DCAT ValueChain Insights websites, Jim covers: Vaccine manufacturing, capacity constraints and the increasing scale and role of the CDMO in the pharma space. 32+ M&A deals already and an outlook for more (and bigger) activity on

en

46:19

The unique general

Molecule to Market: Inside the outsourcing space ·

2021/05/20

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Andrew Moore, General Manager at Pfizer CentreOne. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Andrew, covering: The pride of being part of Pfizer in the last year and first-hand experience of working with CEO Albert Bourla. Lifelong leadership lessons learnt during eight years of military service in Iraq, where decisions cost

en

35:58

The Stickability factor

Molecule to Market: Inside the outsourcing space ·

2021/05/12

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Tom Moody, Vice President of Technology Development and Commercialisation at Almac. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Tom, covering: 20 years at Almac and being on a journey that has seen the company go from a few hundred staff to over 5500 people. The chemistry of today is not the chemistry of tomorrow, including the future

en

50:08

Poacher turned gamekeeper, turned hybrid

Molecule to Market: Inside the outsourcing space ·

2021/04/30

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Peter Bigelow President at xCell Strategic Consulting. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Peter, covering: The transition from being on the big pharma sponsor side at Pfizer to being head of one of the world’s biggest CDMOs. The challenging of adding a development capability to well-oiled manufacturing infrastructure and way

en

58:46

The humble leader

Molecule to Market: Inside the outsourcing space ·

2021/04/21

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Steve Ferguson, Chief Executive Officer at Medix Biochemica. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Steve, covering: The positive and negative impact of Covid-19 on the diagnostic sector. And the need for more spend on diagnostic sector moving forward. How his humble and grounded upbringing gave him an early respect for the

en

36:22

The understated, elite vaccine scientist

Molecule to Market: Inside the outsourcing space ·

2021/04/14

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Archie Lovatt Life Sciences Biosafety Scientific Director at SGS. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Archie, covering: Being motivated by saving lives and seeing your contribution make a real impact on the world. Following your heart and not chasing the money. Seeing Covid-19 drugs developed in a parallel rather than

en

42:57

Creating a healthy culture

Molecule to Market: Inside the outsourcing space ·

2021/04/01

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jeff Dill, CEO at Vynamic. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Jeff, covering:· How to create, document, grow and internationally scale an incredible business culture. The shift towards greater industry collaboration as an important step for quicker drug approvals in the future. Servant leadership philosophy - to listen, be

en

44:22

40 at 40

Molecule to Market: Inside the outsourcing space ·

2021/03/25

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Raman Sehgal Founder & Global President of ramarketing & usual host of the Molecule to Market podcast. Raman has 20+ years of marketing and life science industry experience. Starting his career and setting up his business in the UK, Raman now resides stateside after relocating to the US to open an office in Boston. Raman previously worked for The Specials Laboratory and SCM

en

35:05

From Pfizer to CDMO start-up

Molecule to Market: Inside the outsourcing space ·

2021/03/17

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gerry Cox, Founder and Chief Operating Officer at Velesco Pharmaceutical Services. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Gerry, covering: The transition from two decades in Big Pharma to the entrepreneurial world of running a CDMO. Becoming known as the ‘lab down the hall’ for many clients with products in the clinical phase

en

45:02

Expanding drug dosage possibilities…

Molecule to Market: Inside the outsourcing space ·

2021/03/10

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Megan Greth, Director of Marketing & Business Development and Tadgh Prendeville, General Manager at ARx LLC. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Megan and Tadgh, covering: The developments & demands for new transdermal drug products and oral thin films as a more patient centric drug delivery platform. How the focus on

en

38:32

From Teesside Uni to global leader

Molecule to Market: Inside the outsourcing space ·

2021/03/03

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jarlath Keating President & CEO at ABL Inc. Jarlath has over 25 years of global life science industry experience. Starting his career in the UK in the early 90’s before transitioning to the US in 2009. During this time, Jarlath worked for HyClone and Lonza Biologics. He served as the Vice President of Global Commercial Operations for MilliporeSigma’s Process Solutions Services

en

36:44

The accidental CDMO

Molecule to Market: Inside the outsourcing space ·

2021/02/22

In this episode of Molecule to Market, your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with guest Richard Johnson, Founding Director of Upperton Pharma Solutions. With more than 25 years of experience in the industry, Richard is a founding director of two, successful pharmaceutical companies. He has authored 30 scientific publications and is the named-inventor on more than 20 patents. His research experience spans a broad range of scientific disciplines

en

256 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter